Answers are grounded in this paper and cite their sources.
The work aimed to determine the properties of the vitamin-mineral supplement EvitSel (acute toxicity, toxicity with prolonged subcutaneous administration). In our work, we used the vitamin-mineral supplement EvitSel produced by the NPF ‘Brovapharma’ (Ukraine). To study the acute toxicity of the EvitSel supplement, 30 white mice weighing 18‒20 g and 15 white rats weighing 180‒215 g were used. To determine the acute toxicity, the supplement was administered once in the morning orally through a cannula on an empty stomach in doses of 1300, 2500, and 5000 mg/kg of body weight. To determine the long-term toxicity, it was administered to rats in the experimental group daily subcutaneously for 18 days at a dose of 0.5 ml/kg of body weight. On the twentieth day after the use of the vitamin-mineral supplement EvitSel, all rats in the groups were killed after prior application of ether as anesthesia. At the same time, blood samples were taken to determine the effect of the supplement on blood parameters. The maximum dose of the EvitSel supplement, which did not cause the death of experimental rats and mice with a single oral administration, is greater than the dose of 5000 mg/kg of body weight. There is also no statistically significant effect of the EvitSel supplement, provided that it is administered subcutaneously to laboratory rats for eighteen days at a dose of 0.5 ml/kg of body weight, on weight indicators, indicators of relative increase in the weight of internal organs of rats, and hematological indicators. The vitamin-mineral supplement EvitSel, according to the established acute toxicity indicators, can be attributed to the 5th category according to the International Global Harmonized System (GHS) classification. The vitamin and mineral supplement EvitSel, when administered subcutaneously to laboratory rats for eighteen days at a dose of 0.5 ml/kg of body weight, does not cause any harmful effects on the body of experimental rats, namely, it does not affect their growth and development, does not cause changes in the relative mass of internal organs, and does not lead to changes in hematological parameters in experimental animals
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: